Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines
Phase of Trial: Phase IV
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 25 Dec 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 25 Dec 2009 Actual start date (1 Apr 2007) and actual patient number (754) added as reported by ClinicalTrials.gov.
- 12 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.